Also - Hypothetically of course:
If a cornerstone investor is getting frustrated with board and or management they may short sell the stock against their own long position to - hedge both ways or to deny board / staff SP related performance remuneration / options.
I'd see this as an effective way to spur on lazy / greedy board / management - think knife to throat style - no market notice required as still holds original position and lays out demands. Demands not met - keep shorting till satisfied or hit original holding size in shorts. Further breakdown of relations may see C/Stone reach their holding size in shorts. With an equally long and short position (basically uninvested) I think the CS would have tremendous bargaining power - a ceasing to be a substantial holder notice could be dropped at this point further destabilising the stock and the CS walks away having closed all positions.
As I'm a novice still I would like to be corrected if my understanding (particularly re: disclosure to market) of this is incorrect.
Thanks lanek
GLTAH
- Forums
- ASX - By Stock
- BGL
- BGL - Share Price forecast and results
BGL - Share Price forecast and results, page-253
-
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BGL (ASX) to my watchlist
|
|||||
Last
$1.93 |
Change
0.000(0.00%) |
Mkt cap ! $2.272B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6446 | $2.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.87 | 71 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6446 | 2.120 |
2 | 991 | 2.020 |
9 | 3982 | 1.985 |
1 | 194 | 1.965 |
1 | 147 | 1.950 |
Price($) | Vol. | No. |
---|---|---|
1.870 | 71 | 2 |
1.875 | 705 | 1 |
1.895 | 900 | 1 |
1.900 | 5102 | 3 |
1.905 | 60 | 1 |
Last trade - 09.41am 16/07/2024 (20 minute delay) ? |
Featured News
BGL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online